Emmy-Winning Producer Sarah Caplan Dies at 73
Similar Articles
Audrey Beth Davis, Television Publicist for 'The Golden Girls' and 'Law & Order', Dies at 82
Jennifer Harmon, Soap Opera and Broadway Actress, Dies at 82
Netflix Orders 'Lovesick' Drama Series from Claire Danes and Sarah Treem
Lesli Linka Glatter Reflects on Career and Industry Progress
Rita Wilson Joins HBO Max Drama Pilot 'How to Survive Without Me'
Sarah Caplan, an Emmy-winning television producer known for her work on 'Lost', 'Alias', and 'Crazy Ex-Girlfriend', died on April 30. She had been diagnosed with Alzheimer's disease three years prior. Caplan is survived by her daughter.
Facts First
- Sarah Caplan died on April 30 at Dignitas in Zurich.
- She was 73 years old and had been diagnosed with Alzheimer's disease three years earlier.
- Caplan won an Emmy award for producing the pilot of 'Lost'.
- Her career spanned decades with credits including 'Alias', 'Brothers & Sisters', and 'The Morning Show'.
- She is survived by her daughter, Stella Stahl.
What Happened
Sarah Caplan died on April 30 at Dignitas in Zurich. She was 73 years old and had been diagnosed with Alzheimer's disease three years prior to her death. Caplan was an Emmy-winning television producer whose career included work on the pilots for 'Alias' and 'Lost', the full series of 'Crazy Ex-Girlfriend', and as a co-executive producer on 'The Morning Show'. She is survived by her daughter, Stella Stahl.
Why this Matters to You
The choice to end one's life at a facility like Dignitas, which specializes in assisted dying, brings the topic of end-of-life care and personal autonomy into public discussion. Caplan's death may prompt reflection on how society supports individuals facing terminal illnesses like Alzheimer's. Her extensive career also highlights the often unseen work of producers who shape popular television.
What's Next
Caplan's legacy will continue through her body of work. Her passing may lead to renewed conversations within the entertainment industry and among the public about Alzheimer's disease and end-of-life choices.